Difference between revisions of "Part:BBa K3128018:Experience"

Line 1: Line 1:
<partinfo>BBa_K3128018 short</partinfo>
+
=Team Grenoble-Alpes 2019=
  
==Sequence and features==
+
=='''Materials and Methods'''==
<div style="text-align:justify;"> 
+
This biobrick is composed of the external membrane [https://parts.igem.org/Part:BBa_K3128031 Outer Membrane Protein X Wild Type <i>(OmpX-WT)</i>]
+
protein fused at its N-terminal end to a 54 aa [https://parts.igem.org/wiki/index.php?title=Part:BBa_K3128010 Gly-Gly-Ser Linker (GGS)]
+
followed by the [https://parts.igem.org/wiki/index.php?title=Part:BBa_K1638004 T18 sub-part of the <i>Bordetella Pertussis</i> adenylate cyclase] (AC) .<br>
+
This biobrick is under a constitutive promoter [https://parts.igem.org/Part:BBa_J23101 J23101],
+
thereby OmpX-WT fused to T18 protein is constitutively expressed leading to a large amount of recombinant protein in the outer membrane at any time.<br>
+
 
+
<br>This BioBrick is intended to operate with [https://parts.igem.org/wiki/index.php?title=Part:BBa_K3128018 BBa_K3128018].<br>
+
These two biobricks are the negative condition of the '''mBACTH''' <i>-free sub-parts condition-</i>.<br>
+
OmpX proteins are fused to the adenylate cyclase sub-parts at their N-terminal ends. The fusion protein '''move freely''' in the bacterial outer membrane,
+
but they are not forced to get closer by any mean. <br>
+
The reconstitution of the adenylate cyclase in this condition is only due to random occurrence between both parts.<br>
+
The signal measured is considered as background noise.
+
  
 +
===Bacterial Strain===
 +
<div style="text-align:justify;">
 +
The assays are made with streptomycin resistant '''BTH101''' <i>E.Coli</i> strain, which are <i>cya-</i> bacteria.<br>
 +
In this strain, the endogenous adenylate cyclase gene has been deleted in order to obtain a bacterium that is <u>unable to produce endogenous '''cAMP'''</u>,
 +
thus avoiding the presence of potential false positives and making the system more sensitive.
 
</div>
 
</div>
  
 
+
===Design of the plasmids===
<partinfo>BBa_K3128017 SequenceAndFeatures</partinfo>
+
<div style="text-align:justify;">
 +
For the mBACTH, as three biobricks have to be inserted in the bacterium to constitute the entire system, genetic constructions have been made in order to co-transform only two compatible plasmids:
  
 
<br>
 
<br>
 +
<i>pOT18-Nlc</i> contains '''OmpX gene fused to the T18''' sub-part and the '''NanoLuciferase gene''' under the control of the '''plac promoter'''; it has an ampicillin resistant gene and the pMB1 replication origin.<br>
 +
<i>pOT18-Nlc</i> contains [https://parts.igem.org/Part:BBa_K3128001 NanoLuciferase reporter for BACTH assay] and [https://parts.igem.org/Part:BBa_K3128017 OmpX WT protein fused with T18 subpart of Bordetella Pertussis AC under constitutive promoter].<br>
 +
<i>pOT25</i> contains '''OmpX gene fused to the T25 subpart'''. It has a kanamycin resistant gene and the p15A replication origin.<br>
 +
<i>pOT25</i> contains [https://parts.igem.org/Part:BBa_K3128018 OmpX WT protein fused with T25 subpart of Bordetella Pertussis AC under constitutive promoter].<br>
 +
'''Those constructs will constitute the negative condition that will reveal the background noise of the initial mBACTH system.'''<br>
  
==Usage and Biology==
 
<div style="text-align:justify;"> 
 
In 1989, Fields and Song demonstrated a new genetic system allowing the detection of protein-protein interaction <sup>(1)</sup>. At first, it was performed in ''Saccharomyces cerevisiae''
 
yeast and it was named the yeast two-hybrid assay (Y2H). In 1998, Ladant and al. described the system in bacteria <sup>(2)</sup>. Nowadays, this biological technique is mostly
 
used to show and characterize the physical interaction between two cytosolic proteins or internal membrane proteins <i>in vivo</i> <sup>(3)</sup>.
 
 
<br>
 
<br>
 +
<i>pOT18-Nlc-ZIP</i> is similar to <i>pOT18-Nlc</i> with the addition of a '''leucine-zipper''' sequence between the '''OmpX signal peptide''' and the '''OmpX gene'''.<br>
 +
<i>pOT18-Nlc-ZIP</i> contains [https://parts.igem.org/Part:BBa_K3128001 NanoLuciferase reporter for BACTH assay] and [https://parts.igem.org/wiki/index.php?title=Part:BBa_K3128026 OmpX WT protein fused with LZ and T18 subpart of Bordetella Pertussis AC under constitutive promoter].<br>
 +
<i>pOT25-ZIP</i> is similar to <i>pOT25</i> with the addition of a '''leucine-zipper''' sequence between the '''OmpX signal peptide''' and the '''OmpX gene'''. <br>
 +
<i>pOT25-ZIP</i> contains [https://parts.igem.org/wiki/index.php?title=Part:BBa_K3128027 OmpX WT protein fused with LZ and T25 subpart of Bordetella Pertussis AC under constitutive promoter].<br>
 +
'''Those constructs will constitute the positive condition that will reveal how the signal increases when both sub-parts are brought together with the mBACTH.'''<br>
  
<br>
+
https://2019.igem.org/wiki/images/thumb/f/f9/T--Grenoble-Alpes--mBACTH_plamides.png/800px-T--Grenoble-Alpes--mBACTH_plamides.png
===<u>Bacterial Adenylate Cyclase Two-Hybrid</u> (BACTH)===
+
<div style="text-align:justify;"> 
+
  
<br>The principle lies on the interaction-mediated reconstitution of a signalling cascade in <i>Escherichia coli</i>. The messenger molecule involved in this cascade is the
+
===Transformation===
cyclic adenosine monophosphate (cAMP) produced by the adenylate cyclase. Adenylate cyclase is an enzyme catalysing the cAMP production from ATP. It
+
For the assay with the membrane BACTH, BTH101 are co-transformed either with <u><i>pOT18-Nlc</i> and <i>pOT25</i> plasmids</u> : '''negative condition''',<br>  
physiologically participates to the cellular transmission. <br>
+
or <u><i>pOT18-Nlc-ZIP</i> and <i>pOT25-ZIP</i> plasmids</u> : '''positive condition'''.<br>
 
+
<br>This system involves the <i>Bordetella pertussis</i> '''adenylate cyclase'''. You might know this bacterium; it is the responsible agent for the pertussis disease.
+
It adenylates cyclase catalytic domain has the particularity to be splittable in two distinct parts: '''T18''' and '''T25''' sub-parts, <u>unable to work unless they
+
reassociate.</u> Each sub-part of the enzyme is fused with a protein of interest, either the bait or the prey protein chose beforehand by the experimentator. <br>
+
 
+
<span style="margin: 12%;">
+
https://2019.igem.org/wiki/images/e/ec/T--Grenoble-Alpes--BACTH_classicBACTH.gif
+
</span>
+
 
+
<br>If two proteins interact, then '''T18''' and '''T25''' are bring together and reconstitute a <u>functional adenylate cyclase enzyme</u> thus enabling cAMP production. Using
+
<i>cya-</i> bacteria<i> – strain for whom the adenylate gene is deleted, involving an absence of this endogenous enzyme – </i> a BACTH could be done with the creation of two
+
fusion proteins : the first one, fused at its N or C terminal intracellular end with the '''T18 sub-part'''; the second one fused with the '''T25 sub-part'''. <br>
+
The interaction of these proteins of interest will lead to the adenylate cyclase reconstitution, thus <u>initiating cAMP production</u>. The cAMP produced will act as a
+
messenger by fixing itself to the transcriptional activator CAP, cAMP form the <u>CAP-cAMP</u> complex, controlling the expression of the promoter lactose by '''initiating transcription of the following gene'''. <br>
+
This promoter is placed upstream the chosen reporter gene.<br>
+
</div>
+
  
 +
===The assay===
 +
<div style="text-align:justify;">
 +
To make sure that the '''OmpX-T18''' and '''OmpX-T25''' are expressed in the external membrane, '''OmpX''' fusion proteins have been muted to be able to integrate an unnatural amino acid in one of their extracellular loops by implementing the amber stop codon TAG.
 +
A specific tRNA can then add an azido-modified amino acid to the protein, these modified proteins are called '''COMPs'''.<br>
 +
The azido group of the protein reacts with a DIBO group which process allows to click extracellular DIBO functionnalized biosensor to the protein. <br>
 +
COMPs are fused with T18 or T25 subparts and have to be expressed at the external membrane of the bacteria.<br>
 +
To ensure this, microscopy observations have been done with an '''Dalexia 488''' conjugated '''DIBO''' group. <br>
 +
'''Fluorescent microscopy observations of the COMP, COMP-T18 and COMP-T25 clickable proteins show surface labelled bacteria indicating that a the recombinante proteins are expressed at the external membrane of <i>E. coli.</i> '''<br>
 +
<br>
 +
The bioluminescence intensity produced by the NanoLuciferase enzyme is determined.<br>
 +
Several experimental conditions are tested using decreasing amount of bacterial culture (100µL, 25µL, 5µL and 1µL) at OD600nm = 0.6 : respectively 48E+06 CFU, 12E+06 CFU, 24E+05 CFU and 48E+04 CFU .<br>
 +
In addition, times of induction are tested <u>from 0 to 360 minutes with 30 minutes increments</u>.<br>
 +
Cultures of the different recombinant bacteria are incubated overnight at 18°C under shaking in order to induce an optimal COMPs proteins production [http://2015.igem.org/Team:TU_Eindhoven cf Team Eindhoven 2015].<br>
 +
The low temperature allows a native protein folding and membrane insertion to avoids as much as possible the formation of inclusion bodies.<br>
 +
<br>
 +
Then cultures are diluted at OD600nm = 0,4 and let to grow to OD 600nm = 0.6 before induction.<br>
 +
The induction is performed by addition of '''0,5 mM IPTG''' and '''2mM of ATP''' for different periods of time. Bacteria are incubated at '''37°C''' under shaking (180 rpm) to allow an optimal '''NanoLuciferase production'''.<br>
 +
<br>
 +
After induction, 1, 5, 25 or 100µL of bacteria are distributed in a 96 wells black NUNC plate (ThermoFisher) and the Nano-Glo® Luciferase Assay assay from Promega® is performed [https://france.promega.com/products/reporter-assays-and-transfection/reporter-assays/nano_glo-luciferase-assay-system/?catNum=N1110 (More informations)] : <br>
 +
“Prepare the desired amount of reconstituted Nano-Glo® Luciferase Assay Reagent by combining one volume of Nano-Glo® Luciferase Assay Substrate with 50 volumes of Nano-Glo® Luciferase Assay Buffer.For example, if the experiment requires 10 mL of reagent, add 200μl of substrate to 10 mL of buffer.”<br>
 +
Then the amount of bioluminescence is measured using a luminometer by recording Relative Luminescence Units (RLU).<br>
 +
<br>
 +
Several measures are made in the same well in order to reduce incertitude induced by the luminometer.<br>
 +
In order to test the '''reproducibility''' of our measures the means of '''3 differents experiments''' with '''3 measurements per well''' are calculated. <br>
 +
Data are expressed as the mean +/- standard deviation.<br>
 +
<br>
 +
'''Several controls are performed''':<br>
 +
'''∅ IPTG, ∅ ATP''' : To check the promoter leakage without any induction.<br>
 +
'''∅ IPTG, 2 mM ATP''' :To check if the addition of extracellular ATP helps the production of cAMP and to check if addition of ATP modifies the promoter leakage.<br>
 +
'''0.5 mM IPTG, ∅ ATP''' : To check if adding extracellular ATP is needed for protein expression.<br>
 +
'''0.5 mM IPTG, 2 ATP''' : Is the experimental condition, it correspond to the measure at 360min.<br>
 
<br>
 
<br>
  
===<u>NeuroDrop Project - Outer-Membrane BACTH</u> (mBACTH) ===
+
==Results==
<div style="text-align:justify;">
+
 
<br>
 
<br>
https://static.igem.org/mediawiki/parts/0/0b/BACTH_constructions.gif
+
The '''mBACTH''' following results are obtained with '''5µL''' of bacteria at OD600nm = 0.6 : '''24E+05 CFU'''.<br>
 +
<i>With 1µL (48E+04 CFU), the bioluminescence intensity was too low and the measurement were not discriminant enough.<br>
 +
Above 25µL of bacteria (12E+06 CFU), the signal was quickly saturated when the induction time increased and the luminometer could not record workable measures.<br>
 +
5µL (24E+05 CFU) is a good compromise, it’s enough to have a discriminant signal and sensitive enough to work as a small drop in our NeuroDrop device.<br>
 +
iGEM Grenoble-Alpes device NeuroDrop is designed for the use of small volumes of biological sample like drops.
 +
Proving that 5µL of bacteria are enough to detect a significant difference in bioluminescence intensity between negative and positive conditions result was a challenge that we have overcome.
 +
Other reagents (see the full system) will be added to the drop of bacteria and its volume should not exceed 20µLworkto allow its automatic moving on the surface of the device.</i><br>
 
<br>
 
<br>
<br>[http://2015.igem.org/Team:TU_Eindhoven Eindhoven-2015] iGEM project’s aim was to develop a “universal membrane sensor platform for biosensors”.<br>  
+
https://2019.igem.org/wiki/images/7/77/T--Grenoble-Alpes--mBACTH_Table_1.png <br>
This year, '''Team Grenoble-Alpes''' is designing a new tears biosensor system based on [http://2015.igem.org/Team:TU_Eindhoven Eindhoven-2015]’s project.
+
<i> Means of measurements obtained through 3 differents experiments with 3 measurements per well for each condition of the mBACTH generated with either <br>
Both projects have a common base, the same receptors are used at the external surface of bacteria : '''[https://parts.igem.org/Part:BBa_K1492000 Clickable Outer Membrane Protein X(COMP)]'''. <br>
+
BBa_K3128018 and BBa_K3128017 : '''AC sub-parts  fused to OmpX  : negative condition''',<br>
 +
or BBa_K3128026 and BBa_K3128027 : '''Leucine Zipper  mediated reconstitution of AC : positive condition'''.<br>
 +
Blank was done with 24E+05 CFU of untransformed BTH101 (RLU = 300) and subtracted to each measurements.</i><br>
 +
<br>
 +
Using positive control strain, we measured '''1.48E+06 RLU''' of bioluminescence produced in the '''0.5 mM IPTG''' condition compared to '''9.02E+05''' in the condition '''without IPTG and without ATP''', indicating that <u>IPTG increase slightly the transcription</u>.<br>
 +
Additionally, with '''2.55E+0,6 RLU''' of bioluminescence produced in the condition''' without IPTG and 2mM ATP''' condition compared to '''9.02E+05''' in the '''without IPTG and without ATP condition''', it seems that <u>ATP have a '''significant*''' effect on transcription</u>. <br>
 +
This was expected because of the lack of ATP in the periplasm of the bacteria. Thereby, <u>adding a great amount of ATP in the medium able to diffuse in the periplasm help the cAMP production by the periplasmic adenylate cyclase</u>.<br>
 +
Obviously, those observations do not prove anything but give clues on the way the system operates. <br>
 +
<i>* A T test was done for the values of time above 90 min and led to a p-value below 0.01.</i><br>
 +
<br>
 +
https://2019.igem.org/wiki/images/thumb/7/72/T--Grenoble-Alpes--mBACTH_Graph_1.png/800px-T--Grenoble-Alpes--mBACTH_Graph_1.png <br>
 +
<i><i>Luminescence production over time of induction for the '''negative condition strain (red curve)''' and the '''positive condition strain of the mBACTH assay (blue curve)'''.<br>
 +
Area of the '''significant*''' difference between both curves is highlighted in yellow. <br>
 +
Blank was done with 24E+05 CFU of untransformed BTH101 (RLU = 300) and subtracted to each measurements.<br></i>
 +
<i>* A T test was done for the values of time above 210 min and led to a p-value below 0.05.<br></i>
 +
<br>
 +
<u>From 0 to 120 minutes</u> of induction time, the <u>bioluminescence produced by the two strains is similar</u>. <br>
 +
At '''120 minutes''', the <u>two curves start to split</u> and give rise to a <u>significant difference</u> between the free sub-parts : negative condition and the Leucine Zipper: positive condition from around '''210 minutes'''.<br>
 +
<br>
 +
The discrepancy keeps increasing upon time of induction, thus highlighting the efficiency of the '''amplification signal''' thanks to the signalling cascade and the strong reporter gene.<br>
  
OmpX is an outer membrane protein with the C- and N-termini in the intracellular domain. To be able to use OmpX as a scaffold, a unnatural amino acid needs to be introduced.
+
<u>From 0 to 120 minutes</u> of induction time, the <u>bioluminescence produced by the two strains is similar</u>. <br>
This can be done by implementing the amber stop codon TAG in one of the loops of OmpX via a mutation. With a specific tRNA an azide-functionalized amino acid can be built in,
+
At '''120 minutes''', the <u>two curves start to split</u> and give rise to a <u>significant difference</u> between the two strains from around '''210 minutes''' the negative condition strain compared to the Leucine Zipper_positive condition .<br>
which can be used for the SPAAC click chemistry reaction using DIBO functionalized groups, this modified protein is called '''COMP'''.  
+
<br>
The complex '''aptamer''' fixed to a '''COMP''' is then named a '''COMB''' for '''Clickable Outer Membrane Biosensor'''.<br>
+
The discrepancy keeps increasing upon induction time, thus highlighting the efficiency of the '''amplification signal''' thanks to the signalling cascade and the strong reporter gene.<br>
  
<br>The Grenoble-Alpes team aims to develop an '''Outer membrane Bacterial Adenylate Cyclase Two Hybrid''' <i>(mBACTH)</i>.<br>
+
<br>
In this case, the two adenylate cyclase sub-parts are fused to the N-terminal ends of '''COMPs''' with a [https://parts.igem.org/wiki/index.php?title=Part:BBa_K3128010 Gly-Gly-Ser Linker (GGS)] of 54 amino acids <i>- in order to ensure a sufficient flexibility -</i>.<br>
+
When '''COMBs''' catch the extracellular target, they get closer, thus allowing the reconstitution of a functional adenylate cyclase due to the physical proximity of
+
the two sub-parts.<br>
+
The enzyme is operational again and produce a high quantity of '''cAMP''' <i>(around 17,000 mmol of cAMP formed per mg of adenylate cyclase per minute)</i>,
+
<u>the molecule responsible for the signal transduction in the bacteria</u>.<br>
+
https://static.igem.org/mediawiki/parts/e/ec/BACTH_1.gif <br>
+
  
<br>'''cAMP''' molecules diffuse to the cytoplasm of the bacterium and interact with catabolite activator proteins (CAP) in a ratio 1 to 1.
+
==Conclusion==
Yhen two '''cAMP-CA'''P complexes are needed to activate the <u>expression of the gene under the control of the lactose promoter</u>.<br>
+
'''There is a <u>significant difference between the negative and the positive condition of the mBACTH assay</u>''', <br>
Because of the high quantity of cAMP diffusing in the cytoplasm of the bacterium (2), the reporter gene is continously activated as long as cAMP is produced.<br>
+
'''suggesting that a Bacterial Adenylate Cyclase Two-Hybrid can be successfully performed in the periplasm of bacteria which property is required for the sensing and detection of extracellular molecules.'''<br>
https://static.igem.org/mediawiki/parts/f/fd/BACTH_2.gif <br>
+
 
+
<br>The high enzymatic activity (1) of <i>Bordetella pertussis</i> Adenylate Cyclase generates a high production of '''cAMP''' in presence of ATP in the bacterium
+
thus <u>activating the signalling cascade with the CAP-cAMP dependant promoter</u>.<br>
+
Hence this system is promising because it might have a great sensitivity and may drive a great signal amplification for a low amount of melocules to be detected.<br>
+
</div>
+
 
+
<br>
+
  
==References==
+
==User Reviews==
<i>
+
<!-- DON'T DELETE --><partinfo>BBa_K3128017 StartReviews</partinfo>
<sup>(1)</sup> Fields S, Song O. A novel genetic system to detect protein–protein interactions. Nature [Internet]. 1989<br>
+
<!-- Template for a user review
<sup>(2)</sup> Karimova G, Pidoux J, Ullmann A, Ladant D. A bacterial two-hybrid system based on a reconstituted signal transduction pathway. PNAS [Internet]. 1998<br>
+
{|width='80%' style='border:1px solid gray'
<sup>(3)</sup> Karimova G, Gauliard E, Davi M, P.Ouellette S, Ladant D. Protein–Protein Interaction: Bacterial Two-Hybrid. 2017<br>
+
|-
</i>
+
|width='10%'|
 +
<partinfo>BBa_K3128017 AddReview number</partinfo>
 +
<I>Username</I>
 +
|width='60%' valign='top'|
 +
Enter the review inofrmation here.
 +
|};
 +
<!-- End of the user review template -->
 +
<!-- DON'T DELETE --><partinfo>BBa_K3128017 EndReviews</partinfo>

Revision as of 19:54, 12 October 2019

Team Grenoble-Alpes 2019

Materials and Methods

Bacterial Strain

The assays are made with streptomycin resistant BTH101 E.Coli strain, which are cya- bacteria.
In this strain, the endogenous adenylate cyclase gene has been deleted in order to obtain a bacterium that is unable to produce endogenous cAMP, thus avoiding the presence of potential false positives and making the system more sensitive.

Design of the plasmids

For the mBACTH, as three biobricks have to be inserted in the bacterium to constitute the entire system, genetic constructions have been made in order to co-transform only two compatible plasmids:


pOT18-Nlc contains OmpX gene fused to the T18 sub-part and the NanoLuciferase gene under the control of the plac promoter; it has an ampicillin resistant gene and the pMB1 replication origin.
pOT18-Nlc contains NanoLuciferase reporter for BACTH assay and OmpX WT protein fused with T18 subpart of Bordetella Pertussis AC under constitutive promoter.
pOT25 contains OmpX gene fused to the T25 subpart. It has a kanamycin resistant gene and the p15A replication origin.
pOT25 contains OmpX WT protein fused with T25 subpart of Bordetella Pertussis AC under constitutive promoter.
Those constructs will constitute the negative condition that will reveal the background noise of the initial mBACTH system.


pOT18-Nlc-ZIP is similar to pOT18-Nlc with the addition of a leucine-zipper sequence between the OmpX signal peptide and the OmpX gene.
pOT18-Nlc-ZIP contains NanoLuciferase reporter for BACTH assay and OmpX WT protein fused with LZ and T18 subpart of Bordetella Pertussis AC under constitutive promoter.
pOT25-ZIP is similar to pOT25 with the addition of a leucine-zipper sequence between the OmpX signal peptide and the OmpX gene.
pOT25-ZIP contains OmpX WT protein fused with LZ and T25 subpart of Bordetella Pertussis AC under constitutive promoter.
Those constructs will constitute the positive condition that will reveal how the signal increases when both sub-parts are brought together with the mBACTH.

800px-T--Grenoble-Alpes--mBACTH_plamides.png

Transformation

For the assay with the membrane BACTH, BTH101 are co-transformed either with pOT18-Nlc and pOT25 plasmids : negative condition,
or pOT18-Nlc-ZIP and pOT25-ZIP plasmids : positive condition.

The assay

To make sure that the OmpX-T18 and OmpX-T25 are expressed in the external membrane, OmpX fusion proteins have been muted to be able to integrate an unnatural amino acid in one of their extracellular loops by implementing the amber stop codon TAG. A specific tRNA can then add an azido-modified amino acid to the protein, these modified proteins are called COMPs.
The azido group of the protein reacts with a DIBO group which process allows to click extracellular DIBO functionnalized biosensor to the protein.
COMPs are fused with T18 or T25 subparts and have to be expressed at the external membrane of the bacteria.
To ensure this, microscopy observations have been done with an Dalexia 488 conjugated DIBO group.
Fluorescent microscopy observations of the COMP, COMP-T18 and COMP-T25 clickable proteins show surface labelled bacteria indicating that a the recombinante proteins are expressed at the external membrane of E. coli.

The bioluminescence intensity produced by the NanoLuciferase enzyme is determined.
Several experimental conditions are tested using decreasing amount of bacterial culture (100µL, 25µL, 5µL and 1µL) at OD600nm = 0.6 : respectively 48E+06 CFU, 12E+06 CFU, 24E+05 CFU and 48E+04 CFU .
In addition, times of induction are tested from 0 to 360 minutes with 30 minutes increments.
Cultures of the different recombinant bacteria are incubated overnight at 18°C under shaking in order to induce an optimal COMPs proteins production [http://2015.igem.org/Team:TU_Eindhoven cf Team Eindhoven 2015].
The low temperature allows a native protein folding and membrane insertion to avoids as much as possible the formation of inclusion bodies.

Then cultures are diluted at OD600nm = 0,4 and let to grow to OD 600nm = 0.6 before induction.
The induction is performed by addition of 0,5 mM IPTG and 2mM of ATP for different periods of time. Bacteria are incubated at 37°C under shaking (180 rpm) to allow an optimal NanoLuciferase production.

After induction, 1, 5, 25 or 100µL of bacteria are distributed in a 96 wells black NUNC plate (ThermoFisher) and the Nano-Glo® Luciferase Assay assay from Promega® is performed (More informations) :
“Prepare the desired amount of reconstituted Nano-Glo® Luciferase Assay Reagent by combining one volume of Nano-Glo® Luciferase Assay Substrate with 50 volumes of Nano-Glo® Luciferase Assay Buffer.For example, if the experiment requires 10 mL of reagent, add 200μl of substrate to 10 mL of buffer.”
Then the amount of bioluminescence is measured using a luminometer by recording Relative Luminescence Units (RLU).

Several measures are made in the same well in order to reduce incertitude induced by the luminometer.
In order to test the reproducibility of our measures the means of 3 differents experiments with 3 measurements per well are calculated.
Data are expressed as the mean +/- standard deviation.

Several controls are performed:
∅ IPTG, ∅ ATP : To check the promoter leakage without any induction.
∅ IPTG, 2 mM ATP :To check if the addition of extracellular ATP helps the production of cAMP and to check if addition of ATP modifies the promoter leakage.
0.5 mM IPTG, ∅ ATP : To check if adding extracellular ATP is needed for protein expression.
0.5 mM IPTG, 2 ATP : Is the experimental condition, it correspond to the measure at 360min.

Results


The mBACTH following results are obtained with 5µL of bacteria at OD600nm = 0.6 : 24E+05 CFU.
With 1µL (48E+04 CFU), the bioluminescence intensity was too low and the measurement were not discriminant enough.
Above 25µL of bacteria (12E+06 CFU), the signal was quickly saturated when the induction time increased and the luminometer could not record workable measures.
5µL (24E+05 CFU) is a good compromise, it’s enough to have a discriminant signal and sensitive enough to work as a small drop in our NeuroDrop device.
iGEM Grenoble-Alpes device NeuroDrop is designed for the use of small volumes of biological sample like drops. Proving that 5µL of bacteria are enough to detect a significant difference in bioluminescence intensity between negative and positive conditions result was a challenge that we have overcome. Other reagents (see the full system) will be added to the drop of bacteria and its volume should not exceed 20µLworkto allow its automatic moving on the surface of the device.


T--Grenoble-Alpes--mBACTH_Table_1.png
Means of measurements obtained through 3 differents experiments with 3 measurements per well for each condition of the mBACTH generated with either
BBa_K3128018 and BBa_K3128017 : AC sub-parts fused to OmpX  : negative condition,
or BBa_K3128026 and BBa_K3128027 : Leucine Zipper mediated reconstitution of AC : positive condition.
Blank was done with 24E+05 CFU of untransformed BTH101 (RLU = 300) and subtracted to each measurements.


Using positive control strain, we measured 1.48E+06 RLU of bioluminescence produced in the 0.5 mM IPTG condition compared to 9.02E+05 in the condition without IPTG and without ATP, indicating that IPTG increase slightly the transcription.
Additionally, with 2.55E+0,6 RLU of bioluminescence produced in the condition without IPTG and 2mM ATP condition compared to 9.02E+05 in the without IPTG and without ATP condition, it seems that ATP have a significant* effect on transcription.
This was expected because of the lack of ATP in the periplasm of the bacteria. Thereby, adding a great amount of ATP in the medium able to diffuse in the periplasm help the cAMP production by the periplasmic adenylate cyclase.
Obviously, those observations do not prove anything but give clues on the way the system operates.
* A T test was done for the values of time above 90 min and led to a p-value below 0.01.

800px-T--Grenoble-Alpes--mBACTH_Graph_1.png
<i>Luminescence production over time of induction for the negative condition strain (red curve) and the positive condition strain of the mBACTH assay (blue curve).
Area of the significant* difference between both curves is highlighted in yellow.
Blank was done with 24E+05 CFU of untransformed BTH101 (RLU = 300) and subtracted to each measurements.
* A T test was done for the values of time above 210 min and led to a p-value below 0.05.

From 0 to 120 minutes of induction time, the bioluminescence produced by the two strains is similar.
At 120 minutes, the two curves start to split and give rise to a significant difference between the free sub-parts : negative condition and the Leucine Zipper: positive condition from around 210 minutes.

The discrepancy keeps increasing upon time of induction, thus highlighting the efficiency of the amplification signal thanks to the signalling cascade and the strong reporter gene.

From 0 to 120 minutes of induction time, the bioluminescence produced by the two strains is similar.
At 120 minutes, the two curves start to split and give rise to a significant difference between the two strains from around 210 minutes the negative condition strain compared to the Leucine Zipper_positive condition .

The discrepancy keeps increasing upon induction time, thus highlighting the efficiency of the amplification signal thanks to the signalling cascade and the strong reporter gene.


Conclusion

There is a significant difference between the negative and the positive condition of the mBACTH assay,
suggesting that a Bacterial Adenylate Cyclase Two-Hybrid can be successfully performed in the periplasm of bacteria which property is required for the sensing and detection of extracellular molecules.

User Reviews

UNIQee92cc1b4e34cb24-partinfo-00000000-QINU

UNIQee92cc1b4e34cb24-partinfo-00000001-QINU